Femtosecond is highly reproducible & accurate

Article

Femtosecond lasers create highly reproducible flaps that correspond with preoperative intended thickness.

Femtosecond lasers create highly reproducible flaps that correspond with preoperative intended thickness, according to the results of a study published in the January issue of the Journal of Cataract and Refractive Surgery.

Jin-Hyoung Kim and co-workers from Inje University and Rhee's Eye Hospital, Korea compared ultrasound pachymetry, Orbscan and optical coherence tomography (OCT) measurements of central corneal thickness (CCT) before LASIK and evaluated the reproducibility of flaps created with a femtosecond laser, in 59 eyes of 30 patients.

OCT, ultrasound pachymetry and Orbscan measurements provided similar CCT values (p>0.05). Corneal thickness values obtained using ultrasound pachymetry or Orbscan correlated well with those obtained with OCT, with the correlation coefficient ranging from 0.804 to 0.889 (p<0.05). The OCT measurements of flap thickness showed no significant difference between the postoperative measurements and the intended flap thickness (p>0.05).

This study demonstrates that femtosecond lasers are an accurate method of producing intended flap thicknesses.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.